| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |